# Zscaler, Inc.: financial statements, quarterly

ZS · Nasdaq · CIK 1713683 · [Technology](/sectors/technology.md) · fiscal year ends Jul 31

Pages: [Overview](/companies/zs.md) · [Financials](/companies/zs/financials.md) · [Filings](/companies/zs/filings.md) · [Insiders](/companies/zs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/zs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | Q4 FY2024 (2024-07-31) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q4 FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | Q4 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [497](/filings/0001713683-24-000150.md) | [525](/filings/0001713683-25-000033.md) | [553](/filings/0001713683-25-000079.md) | [593 d](/filings/0001713683-26-000157.md) | [628](/filings/0001713683-25-000205.md) | [648](/filings/0001713683-26-000048.md) | [678](/filings/0001713683-26-000096.md) | [719 d](/filings/0001713683-26-000157.md) | [788](/filings/0001713683-25-000205.md) | [816](/filings/0001713683-26-000048.md) | [850](/filings/0001713683-26-000096.md) | [898 d](/filings/0001713683-26-000157.md) |
| Cost of revenue | $m | [111](/filings/0001713683-24-000150.md) | [117](/filings/0001713683-25-000033.md) | [118](/filings/0001713683-25-000079.md) | [130 d](/filings/0001713683-26-000157.md) | [141](/filings/0001713683-25-000205.md) | [148](/filings/0001713683-26-000048.md) | [156](/filings/0001713683-26-000096.md) | [172 d](/filings/0001713683-26-000157.md) | [185](/filings/0001713683-25-000205.md) | [191](/filings/0001713683-26-000048.md) | [193](/filings/0001713683-26-000096.md) | [209 d](/filings/0001713683-26-000157.md) |
| Gross profit | $m | [385](/filings/0001713683-24-000150.md) | [408](/filings/0001713683-25-000033.md) | [435](/filings/0001713683-25-000079.md) | [463 d](/filings/0001713683-26-000157.md) | [486](/filings/0001713683-25-000205.md) | [499](/filings/0001713683-26-000048.md) | [522](/filings/0001713683-26-000096.md) | [547 d](/filings/0001713683-26-000157.md) | [603](/filings/0001713683-25-000205.md) | [624](/filings/0001713683-26-000048.md) | [658](/filings/0001713683-26-000096.md) | [689 d](/filings/0001713683-26-000157.md) |
| Research and development | $m | [114](/filings/0001713683-24-000150.md) | [122](/filings/0001713683-25-000033.md) | [125](/filings/0001713683-25-000079.md) | [139 d](/filings/0001713683-26-000157.md) | [154](/filings/0001713683-25-000205.md) | [171](/filings/0001713683-26-000048.md) | [170](/filings/0001713683-26-000096.md) | [178 d](/filings/0001713683-26-000157.md) | [200](/filings/0001713683-25-000205.md) | [229](/filings/0001713683-26-000048.md) | [232](/filings/0001713683-26-000096.md) | [241 d](/filings/0001713683-26-000157.md) |
| Operating income | $m | [(46.1)](/filings/0001713683-24-000150.md) | [(45.5)](/filings/0001713683-25-000033.md) | [(3.0)](/filings/0001713683-25-000079.md) | [(27.0) d](/filings/0001713683-26-000157.md) | [(30.7)](/filings/0001713683-25-000205.md) | [(40.1)](/filings/0001713683-26-000048.md) | [(25.4)](/filings/0001713683-26-000096.md) | [(32.2) d](/filings/0001713683-26-000157.md) | [(36.4)](/filings/0001713683-25-000205.md) | [(51.8)](/filings/0001713683-26-000048.md) | [(29.6)](/filings/0001713683-26-000096.md) | [(15.5) d](/filings/0001713683-26-000157.md) |
| Interest expense | $m | [3.2](/filings/0001713683-23-000171.md) | [3.6](/filings/0001713683-24-000041.md) | [2.8](/filings/0001713683-24-000075.md) | [3.6 d](/filings/0001713683-26-000157.md) | [3.1](/filings/0001713683-25-000205.md) | [2.3](/filings/0001713683-26-000048.md) | [2.0](/filings/0001713683-26-000096.md) | [2.1 d](/filings/0001713683-26-000157.md) | [2.1](/filings/0001713683-25-000205.md) | [4.2](/filings/0001713683-26-000048.md) | [2.7](/filings/0001713683-26-000096.md) | [2.7 d](/filings/0001713683-26-000157.md) |
| Income tax | $m | [9.0](/filings/0001713683-24-000150.md) | [8.0](/filings/0001713683-25-000033.md) | [1.7](/filings/0001713683-25-000079.md) | [9.8 d](/filings/0001713683-26-000157.md) | [7.6](/filings/0001713683-25-000205.md) | [(8.8)](/filings/0001713683-26-000048.md) | [8.7](/filings/0001713683-26-000096.md) | [15.7 d](/filings/0001713683-26-000157.md) | [3.2](/filings/0001713683-25-000205.md) | [13.0](/filings/0001713683-26-000048.md) | [11.5](/filings/0001713683-26-000096.md) | [18.3 d](/filings/0001713683-26-000157.md) |
| Net income | $m | [(33.5)](/filings/0001713683-24-000150.md) | [(28.5)](/filings/0001713683-25-000033.md) | [19.1](/filings/0001713683-25-000079.md) | [(14.9) d](/filings/0001713683-26-000157.md) | [(12.1)](/filings/0001713683-25-000205.md) | [(7.7)](/filings/0001713683-26-000048.md) | [(4.1)](/filings/0001713683-26-000096.md) | [(17.6) d](/filings/0001713683-26-000157.md) | [(11.6)](/filings/0001713683-25-000205.md) | [(34.3)](/filings/0001713683-26-000048.md) | [(13.9)](/filings/0001713683-26-000096.md) | [(3.4) d](/filings/0001713683-26-000157.md) |
| Diluted EPS | $ per share | [(0.23)](/filings/0001713683-24-000150.md) | [(0.19)](/filings/0001713683-25-000033.md) | [0.12](/filings/0001713683-25-000079.md) | not reported | [(0.08)](/filings/0001713683-25-000205.md) | [(0.05)](/filings/0001713683-26-000048.md) | [(0.03)](/filings/0001713683-26-000096.md) | not reported | [(0.07)](/filings/0001713683-25-000205.md) | [(0.21)](/filings/0001713683-26-000048.md) | [(0.09)](/filings/0001713683-26-000096.md) | not reported |
| Basic EPS | $ per share | [(0.23)](/filings/0001713683-24-000150.md) | [(0.19)](/filings/0001713683-25-000033.md) | [0.13](/filings/0001713683-25-000079.md) | not reported | [(0.08)](/filings/0001713683-25-000205.md) | [(0.05)](/filings/0001713683-26-000048.md) | [(0.03)](/filings/0001713683-26-000096.md) | not reported | [(0.07)](/filings/0001713683-25-000205.md) | [(0.21)](/filings/0001713683-26-000048.md) | [(0.09)](/filings/0001713683-26-000096.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | FY2024 (2024-07-31) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1,362](/filings/0001713683-23-000171.md) | [1,439](/filings/0001713683-24-000041.md) | [1,259](/filings/0001713683-24-000075.md) | [1,423](/filings/0001713683-25-000158.md) | [1,554](/filings/0001713683-24-000150.md) | [1,759](/filings/0001713683-25-000033.md) | [1,991](/filings/0001713683-25-000079.md) | [2,389](/filings/0001713683-26-000157.md) | [1,338](/filings/0001713683-25-000205.md) | [1,203](/filings/0001713683-26-000048.md) | [982](/filings/0001713683-26-000096.md) | [928](/filings/0001713683-26-000157.md) |
| Current assets | $m | [2,892](/filings/0001713683-23-000171.md) | [3,143](/filings/0001713683-24-000041.md) | [2,970](/filings/0001713683-24-000075.md) | [3,397](/filings/0001713683-25-000158.md) | [3,394](/filings/0001713683-24-000150.md) | [3,665](/filings/0001713683-25-000033.md) | [3,915](/filings/0001713683-25-000079.md) | [4,894](/filings/0001713683-26-000157.md) | [4,206](/filings/0001713683-25-000205.md) | [4,451](/filings/0001713683-26-000048.md) | [4,654](/filings/0001713683-26-000096.md) | [5,031](/filings/0001713683-26-000157.md) |
| Total assets | $m | [3,636](/filings/0001713683-23-000171.md) | [3,934](/filings/0001713683-24-000041.md) | [4,199](/filings/0001713683-24-000075.md) | [4,705](/filings/0001713683-25-000158.md) | [4,709](/filings/0001713683-24-000150.md) | [5,006](/filings/0001713683-25-000033.md) | [5,340](/filings/0001713683-25-000079.md) | [6,420](/filings/0001713683-26-000157.md) | [6,503](/filings/0001713683-25-000205.md) | [6,754](/filings/0001713683-26-000048.md) | [7,098](/filings/0001713683-26-000096.md) | [7,867](/filings/0001713683-26-000157.md) |
| Current liabilities | $m | [1,474](/filings/0001713683-23-000171.md) | [1,584](/filings/0001713683-24-000041.md) | [1,701](/filings/0001713683-24-000075.md) | [3,113](/filings/0001713683-25-000158.md) | [2,964](/filings/0001713683-24-000150.md) | [3,049](/filings/0001713683-25-000033.md) | [3,168](/filings/0001713683-25-000079.md) | [2,430](/filings/0001713683-26-000157.md) | [2,306](/filings/0001713683-25-000205.md) | [2,341](/filings/0001713683-26-000048.md) | [2,501](/filings/0001713683-26-000096.md) | [2,961](/filings/0001713683-26-000157.md) |
| Total liabilities | $m | [2,828](/filings/0001713683-23-000171.md) | [2,975](/filings/0001713683-24-000041.md) | [3,106](/filings/0001713683-24-000075.md) | [3,431](/filings/0001713683-25-000158.md) | [3,280](/filings/0001713683-24-000150.md) | [3,399](/filings/0001713683-25-000033.md) | [3,535](/filings/0001713683-25-000079.md) | [4,621](/filings/0001713683-26-000157.md) | [4,521](/filings/0001713683-25-000205.md) | [4,558](/filings/0001713683-26-000048.md) | [4,731](/filings/0001713683-26-000096.md) | [5,268](/filings/0001713683-26-000157.md) |
| Long-term debt | $m | [1,134](/filings/0001713683-23-000171.md) | [1,141](/filings/0001713683-24-000041.md) | [1,138](/filings/0001713683-24-000075.md) | [1,142](/filings/0001713683-25-000079.md) | [1,146](/filings/0001713683-24-000150.md) | [1,148](/filings/0001713683-25-000033.md) | [1,149](/filings/0001713683-25-000079.md) | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [808](/filings/0001713683-25-000033.md) | [959](/filings/0001713683-25-000079.md) | [1,093](/filings/0001713683-25-000079.md) | [1,274](/filings/0001713683-26-000157.md) | [1,429](/filings/0001713683-26-000048.md) | [1,607](/filings/0001713683-26-000096.md) | [1,805](/filings/0001713683-26-000096.md) | [1,799](/filings/0001713683-26-000157.md) | [1,982](/filings/0001713683-26-000048.md) | [2,196](/filings/0001713683-26-000096.md) | [2,367](/filings/0001713683-26-000096.md) | [2,598](/filings/0001713683-26-000157.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | Q4 FY2024 (2024-07-31) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q4 FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | Q4 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [261](/filings/0001713683-24-000150.md) | [142 d](/filings/0001713683-25-000033.md) | [173 d](/filings/0001713683-25-000079.md) | [204 d](/filings/0001713683-26-000157.md) | [331](/filings/0001713683-25-000205.md) | [179 d](/filings/0001713683-26-000048.md) | [211 d](/filings/0001713683-26-000096.md) | [251 d](/filings/0001713683-26-000157.md) | [448](/filings/0001713683-25-000205.md) | [204 d](/filings/0001713683-26-000048.md) | [198 d](/filings/0001713683-26-000096.md) | [279 d](/filings/0001713683-26-000157.md) |
| Capital expenditure | $m | [28.7](/filings/0001713683-24-000150.md) | [30.9 d](/filings/0001713683-25-000033.md) | [35.7 d](/filings/0001713683-25-000079.md) | [49.4 d](/filings/0001713683-26-000157.md) | [17.0](/filings/0001713683-25-000205.md) | [15.0 d](/filings/0001713683-26-000048.md) | [72.2 d](/filings/0001713683-26-000096.md) | [60.0 d](/filings/0001713683-26-000157.md) | [17.3](/filings/0001713683-25-000205.md) | [17.8 d](/filings/0001713683-26-000048.md) | [42.4 d](/filings/0001713683-26-000096.md) | [200 d](/filings/0001713683-26-000157.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2022-10-31) | Q2 FY2023 (2023-01-31) | Q3 FY2023 (2023-04-30) | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [143](/filings/0001713683-23-000171.md) | [145](/filings/0001713683-24-000041.md) | [145](/filings/0001713683-24-000075.md) | [148](/filings/0001713683-24-000150.md) | [149](/filings/0001713683-25-000033.md) | [154](/filings/0001713683-25-000079.md) | [153](/filings/0001713683-25-000205.md) | [154](/filings/0001713683-26-000048.md) | [155](/filings/0001713683-26-000096.md) | [159](/filings/0001713683-25-000205.md) | [160](/filings/0001713683-26-000048.md) | [161](/filings/0001713683-26-000096.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 163,054,698 at 2026-08-27, from the cover of the [10-K filed 2026-09-03](/filings/0001713683-26-000157.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.